Recurrent IgA Nephropathy After Kidney Transplantation

In Brief Large numbers of patients with end-stage kidney disease caused by IgA nephropathy are transplanted every year, and each of these patients faces the risk of recurrence in their kidney graft. We review the epidemiology, diagnosis, and outcomes of recurrent IgA nephropathy. Mechanistic insights, therapeutic options, and knowledge gaps are reviewed, and we discuss future options to better understand and manage this disorder. This article reviews the epidemiology, diagnosis and outcomes of recurrent IgA nephropathy in renal transplantation and explores mechanistic insights and therapeutic options as well as identifying knowledge gaps in our understanding of this disease.